MedTrace Logo

Low-Sodium Diet for Postpartum Blood Pressure Control

NCT07752056 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-08-12

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to learn if a low-sodium diet improves postpartum blood pressure control in adults who were diagnosed with a late-onset hypertensive disorder of pregnancy.

The main questions it aims to answer are:

* Does a low-sodium diet lead to decreased mean arterial blood pressure (MAP) on postpartum day 7?
* Does a low-sodium diet lead to a decreased MAP on postpartum day 3?
* Does a low-sodium diet reduce 30-day hospital readmissions for hypertension-related indications?

Participants will be provided with meals for 7 days following their delivery. The experimental diet will contain less than 2000mg of sodium daily. The control diet will have variable sodium content with no restrictions. Participants will be asked to record the food they consume over the study week. They will also be provided with a blood pressure (BP) cuff and asked to record their BP at least once daily.

Conditions

  • Hypertensive Disorder of Pregnancy
  • Pre-Eclampsia, Severe
  • Pre-Eclampsia; Mild
  • Postpartum

Interventions

OTHER

Low Sodium Diet

7-day provided diet with total daily sodium intake restricted to less than 2000mg

Sponsors & Collaborators

  • Meals on Wheels Rhode Island (MOWRI)

    collaborator UNKNOWN

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Adam Lewkowitz, MD · Care New England

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07752056 on ClinicalTrials.gov